Get the Stockscreener App
21.95
1.88%
-0.42
After Hours:
21.95
Surgery Partners Inc stock is traded at $21.95, with a volume of 1.48M.
It is down -1.88% in the last 24 hours and down -1.26% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$22.37
Open:
$22.21
24h Volume:
1.48M
Relative Volume:
0.98
Market Cap:
$2.81B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-81.30
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
+4.47%
1M Performance:
-1.26%
6M Performance:
-13.89%
1Y Performance:
-27.70%
1-Day Range:
$21.90
$22.34
1-Week Range:
$20.65
$22.60
52-Week Range:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
21.95 | 2.87B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
353.99 | 85.42B | 72.70B | 5.97B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
161.28 | 14.21B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.34 | 15.14B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
110.11 | 11.08B | 5.51B | 494.70M | 386.40M | 4.84 |
|
DVA
Davita Inc
|
140.37 | 10.93B | 12.82B | 936.34M | 1.47B | 10.74 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
What are the latest earnings results for Surgery Partners Inc.AI Powered Updates From AI Tools - jammulinksnews.com
Is Surgery Partners Inc. stock overvalued or undervaluedBeginner Investor Planner With High Returns - jammulinksnews.com
United Surgical Partners’ $1.5 Million 401(k) Deal Moves Forward - Bloomberg Law News
Why Surgery Partners Inc. stock attracts strong analyst attentionLow Capital High Return Stock Plans Reviewed - beatles.ru
RSI Crosses Above 30 for Surgery Partners Inc. — Reversal in SightConservative Entry for High Return Setup Backed - beatles.ru
Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know - Yahoo Finance
Published on: 2025-07-29 21:06:02 - metal.it
Short Term Trend Reversal in Surgery Partners Inc. PossibleInvestment Plan With Growth Optimization Finalized - metal.it
Surgery Partners Stock Rises After Bank of America's Buy RatingNews and Statistics - IndexBox
Surgery Partners (SGRY) Stock Trades Up, Here Is Why - Yahoo Finance
Why Surgery Partners Stock is Climbing High - TipRanks
Why is Surgery Partners Inc. stock attracting strong analyst attentionBuild wealth with long-term growth strategies - jammulinksnews.com
Surgery Partners stock rating resumed at Buy by BofA Securities - Investing.com Canada
How many analysts rate Surgery Partners Inc. as a “Buy”Invest confidently with data-backed picks - jammulinksnews.com
What are the technical indicators suggesting about Surgery Partners Inc.Maximize your portfolio’s growth potential - jammulinksnews.com
What is Surgery Partners Inc. company’s growth strategyAchieve triple-digit returns with smart investing - jammulinksnews.com
How Surgery Partners Inc. stock performs during market volatilityStrategic High Profit Opportunities - metal.it
Surgery Partners Inc. Stock Analysis and ForecastOutstanding capital appreciation - PrintWeekIndia
Is Surgery Partners Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
Does Surgery Partners Inc. stock pay reliable dividendsDynamic portfolio growth - jammulinksnews.com
What analysts say about Surgery Partners Inc. stockUnprecedented profits - Autocar Professional
What drives Surgery Partners Inc. stock priceOutperformance with explosive growth - jammulinksnews.com
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Re - GuruFocus
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details - The Manila Times
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details | SGRY Stock News - GuruFocus
Surgery Partners Sets Q2 Earnings Date: Key Financial Updates Coming August 5 - Stock Titan
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):